Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.
about
Risk factors for mortality in TB patients: a 10-year electronic record review in a South African provinceDiagnostic accuracy of the WHO clinical staging system for defining eligibility for ART in sub-Saharan Africa: a systematic review and meta-analysis.Regression discontinuity designs in epidemiology: causal inference without randomized trials.Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis.Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients.Attrition through multiple stages of pre-treatment and ART HIV care in South AfricaA novel approach to accounting for loss to follow-up when estimating the relationship between CD4 Count at ART initiation and mortality.Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review.Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones, Southern Nations, Nationalities and Peoples Region, EthiopiaCurrent strategies for improving access and adherence to antiretroviral therapies in resource-limited settings.Predictors of linkage to care following community-based HIV counseling and testing in rural KenyaCohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa.Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting.Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa.Entry, Retention, and Virological Suppression in an HIV Cohort Study in India: Description of the Cascade of Care and Implications for Reducing HIV-Related Mortality in Low- and Middle-Income Countries.Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis.Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A retrospective cohort study from 2005 to 2013Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study.Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda.Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study.Prognosis of HIV Patients Receiving Antiretroviral Therapy According to CD4 Counts: A Long-term Follow-up study in Yunnan, China.Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.Clinical progression of severely immunosuppressed HIV-infected patients depends on virological and immunological improvement irrespective of baseline status.Retention in HIV care among female sex workers in the Dominican Republic: implications for research, policy and programming.Pattern of linkage and retention in HIV care continuum among patients attending referral HIV care clinic in private sector in India.Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.High Proportions of Patients With Advanced HIV Are Antiretroviral Therapy Experienced: Hospitalization Outcomes From 2 Sub-Saharan African Sites.
P2860
Q28364961-BDDA28D8-545F-48B5-9F91-222CCCAAF92CQ33755986-5AB4A4A5-6C22-4253-94CE-43860B90CE3BQ34171225-A607A109-2BFD-4FB2-85DF-AB604F2D5287Q34277977-FB728BEA-F2E1-43B5-AED6-ACC508A47F0AQ34311748-F201BC67-7789-49F0-8C6C-1A54CA42F7AAQ34374074-818D42FA-3A86-4444-BC27-71FDAED3DDA1Q34919727-CB76A065-8F97-4DBF-A15E-802F4B67C546Q34969496-CB9491E4-A7A1-4225-A32E-7C9B392D5041Q35756709-D562179F-46E8-4453-B46E-A2AEF0C69262Q36530478-BA1FF3D2-0A95-4214-8302-BF5D2C4DD546Q36664055-40AE627B-578E-4C47-A908-73B67B2F40BFQ36749434-06240C3A-61A1-4FD5-B5BA-5BCF8E655780Q36823151-48EE992B-0898-4C84-9A19-300EA1560898Q37029920-D2FD992F-1317-465A-9C25-1CC88622ED52Q37045224-917381E7-6CE1-4B82-9FB7-EB1591F0F07BQ37112617-97BAFF0B-6F6E-4449-8ACA-C64E9F4E888DQ37327900-53C3D030-036F-401E-A547-4137161182B5Q37461125-B6309C78-75C6-4CCB-9357-2246FE768CC5Q37529362-43499E4D-0FE1-410F-A121-655CA52C8A07Q37538750-385E35FE-47DE-4364-8C45-7FB0B883EACDQ38088726-97C8F1B2-C903-4A2F-8E64-E7C5E87FDBCFQ39297017-46CD0BC8-4FC4-478B-AEA2-E0407EFE61E1Q39347096-14C04144-FA2D-43B9-B65A-816DEA349136Q39678239-E0631E6A-0277-4E8B-9F70-D4443CB31C4CQ40075594-B8BCD6F4-D670-4675-ABB2-8BDCE2F73582Q40623733-6D521A2D-1A7E-468B-93CA-4B62D20575ACQ40979736-3A2F3107-EB60-48F1-B549-3217C997ECC4Q41558330-BA490E8B-1B08-4C11-9E63-D82A4CE879A8Q41563399-85180C1F-9DCC-4B67-A902-4583E2112839Q42237320-BB20A14B-2476-4F8B-8CFE-AC0A4FAC3F38Q52669144-C8EBB3D2-B6BA-424A-B10C-560A434F9F38
P2860
Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Initiating patients on antiret ...... ment outcomes in South Africa.
@ast
Initiating patients on antiret ...... ment outcomes in South Africa.
@en
Initiating patients on antiret ...... ment outcomes in South Africa.
@nl
type
label
Initiating patients on antiret ...... ment outcomes in South Africa.
@ast
Initiating patients on antiret ...... ment outcomes in South Africa.
@en
Initiating patients on antiret ...... ment outcomes in South Africa.
@nl
prefLabel
Initiating patients on antiret ...... ment outcomes in South Africa.
@ast
Initiating patients on antiret ...... ment outcomes in South Africa.
@en
Initiating patients on antiret ...... ment outcomes in South Africa.
@nl
P2093
P2860
P50
P1433
P1476
Initiating patients on antiret ...... ment outcomes in South Africa.
@en
P2093
Francesca Conradie
Ian M Sanne
James McIntyre
Jennifer Zeinecker
Marjorie Dehlinger
Mohammed Rassool
Prudence Ive
P2860
P304
P356
10.1097/QAD.0B013E32833C703E
P407
P577
2010-08-01T00:00:00Z